Carebook Technologies Inc (TSE:CRBK) has released an update.
Carebook Technologies Inc. has reported a robust 43% increase in Q1 2024 revenues, reaching $3.6 million, alongside a positive adjusted EBITDA and a reduction in net losses compared to Q1 2023. The company attributes this growth to strong organic expansion, particularly in the pharmacy vertical, and improved operating margins. Despite higher research and development costs, Carebook is optimistic about maintaining revenue growth and improving profit margins through cost management.
For further insights into TSE:CRBK stock, check out TipRanks’ Stock Analysis page.
